Context Although glycated hemoglobin A1c is currently the best parameter used clinically to
assess risk for the development of diabetes complications, it does not provide insight into …

A new cardiometabolic-based chronic disease (CMBCD) model is presented that provides a
basis for early and sustainable, evidence-based therapeutic targeting to promote …

At present, the global incidence of diabetes has increased in countries with large
populations, and the changes in develo** regions are particularly worthy of attention. In …

Over the past two decades, there has been continuous advancement in the accuracy and
complexity of continuous glucose monitoring devices. Continuous glucose monitoring …

Aims CVD is the main cause of morbidity and mortality in individuals with diabetes. It is
currently unclear whether daily glucose variability contributes to CVD. Therefore, we …

Background To investigate the effect of visit-to-visit fasting plasma glucose (FPG) variability
on the left cardiac structure and function in patients with type 2 diabetes mellitus (T2DM) …

Background The association between glucose variability and the progression of
atherosclerosis is not completely understood. We aimed to evaluate the associations of …

Background This study investigated whether visit-to-visit fasting plasma glucose (FPG)
variability, as measured by the coefficient of variation (CV), increased peripheral artery …

Abstract Rehmannia Radix Polysaccharides (RRPs) are biopolymers that are isolated and
purified from the roots of Rehmannia glutinosa Libosch, which have attracted considerable …

Glycated hemoglobin (HbA1c) variability is emerging as an indicator of long-term glycemic
control, which may play a significant role during vascular complications. We conducted a …